Stocks

Alphabet's Q2 Revenue Rises 7 Percent to $74.6B

 Stocks

Alphabet Inc. (GOOGL) reported earlier today, on July 26, that its Q2 revenue reached $74.6 billion, up 7% annually and beating expectations.

July 26, 2023

views 1326
Intel and Colgate-Palmolive Posted Extremely Weak Earnings Results, While Tesla and Chevron Bested Forecasts

Intel and Colgate-Palmolive Posted Extremely Weak Earnings Results, While Tesla and Chevron Bested Forecasts

U.S. stocks are headed for another lukewarm week after yesterday’s strong rebound.

January 27, 2023

views 1473
China’s Economy Grew by 3.9 Percent in Q3 2022

China’s Economy Grew by 3.9 Percent in Q3 2022

U.S. stock futures rose Sunday evening after all three major averages notched their best week since June at Friday's close.

October 24, 2022

views 1509
Alphabet: Yet Another Brilliant Quarter Enhanced by Upcoming Stock Split Benefits

Alphabet: Yet Another Brilliant Quarter Enhanced by Upcoming Stock Split Benefits

Alphabet (GOOGL) (GOOG) put out an impressive quarterly result yesterday. Alphabet put a sizzling performance, with Q4 2021 reporting 32% YoY revenue growth.

February 2, 2022

views 1609

Popular posts

Stocks

Apple February MoM iPhone Sales down 9% in U.S., 16% in China.

April 1, 2024

views 2975
Cryptocurrencies

Elon Musk's Tesla has Added a Dogcoin (DOGE) Payment Form to its Website. The Meme Coin Soars.

May 6, 2024

views 2968
Stocks

JPMorgan's Q1 Revenue Up by 9% to $41.93 Billion, but Guidance Disappointed

April 12, 2024

views 2887
Commodities

Global Grain Price Recoveries Appears Excessively Bullish vis-à-vis Inventories and Weather Factors

April 24, 2024

views 2867
Currencies

USD May Return to Strengthening on Disappointing Inflation Report

April 10, 2024

views 2818
show more

Tech summary box

top crypto

© 2024 DRT

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the Dr Trade Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.